Cargando…
Chemical synthesis of lipophilic methylene blue analogues which increase mitochondrial biogenesis and frataxin levels
As part of an ongoing program to develop potential therapeutic agents for the treatment of the neurodegenerative disease Friedreich׳s ataxia (FRDA), we have prepared a number of lipophilic methylene blue analogues. Some of these compounds significantly increase mitochondrial biogenesis and frataxin...
Autores principales: | Bandyopadhyay, Indrajit, Chowdhury, Sandipan Roy, Visavadiya, Nishant P., Hecht, Sidney M., Khdour, Omar M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139889/ https://www.ncbi.nlm.nih.gov/pubmed/30225325 http://dx.doi.org/10.1016/j.dib.2018.08.156 |
Ejemplares similares
-
Towards Asymmetrical Methylene Blue Analogues: Synthesis and Reactivity of 3-N′-Arylaminophenothiazines
por: Khadieva, Alena, et al.
Publicado: (2022) -
Mitochondrial Fe-S cluster biogenesis, frataxin and the modulation of susceptibility to drug-induced cardiomyopathy
por: Sack, Michael N.
Publicado: (2010) -
Continuous versus intermittent methylene blue administration: which spin will win?
por: Senthilkumaran, Subramanian, et al.
Publicado: (2014) -
Methylene Blue: Revisited
por: Ginimuge, Prashant R., et al.
Publicado: (2010) -
Methylene-Blue in Fevers
por: Frost, G. H.
Publicado: (1908)